Medication reconciliation and adherence: a call for clinical pharmacist


Autoria(s): Vercelino, Juçara Guiçardi; Maia, Livia Alves; Paz, Karine Dal; Garcia, Primavera Borelli; Ribeiro, Eliane
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

15/09/2014

15/09/2014

2013

Resumo

Introduction and Objectives: With the population ageing, there is a growing number of people who have several comorbidities and make use of a variety of drugs. These factors lead to a greater predisposition to adverse drug events, as well as to medication errors. The clinical pharmacist is the most indicated health professional to target these issues. The aims of this study were to analyze the profile of medication reconciliation and assess the role of the clinical pharmacist regarding medication adherence. Material and Methods: Prospective observational cohort study conducted from Jan-Mar 2013 at the Surgical Clinic of the University Hospital of the University of Sao Paulo. 117 admitted patients - over the age of 18 years, under continuous medication use and with length of hospitalization up to 120h - were included. Discrepancies were classified as intentional/unintentional and according to their risk to cause harm, and interventions were divided into accepted/not accepted. Medication adherence was measured by Morisky questionnaire. Results and Conclusions: Only 30% of hospital prescriptions showed no discrepancies between the medications that the patient was using at home and those which were being prescribed at the hospital and more than one third of those had the potential to cause moderate discomfort or clinical deterioration. One third of total discrepancies were classified as unintentional. About 90% of the interventions were accepted by the medical staff. In addition, about 63% of patients had poor adherence to drug therapy. The study revealed the importance of the medication reconciliation at patient admission, ensuring greater safety and therapeutic efficacy of the treatment during hospitalization, and orienting the patient at discharge, assuring the therapy safety.

Apresentado no XVIII Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences; III Symphosium on drug design and development for Neglected Diseases; V Workshop on Melanoma, skin and photoprotection - Faculty of Pharmaceutical Sciences University of São Paulo - October 21-25, 2013 - São Paulo - Brazil

Identificador

Brazilian Journal of Pharmaceutical Sciences, São Paulo, v. 49, suppl. 1, p. 49, 2013

http://www.producao.usp.br/handle/BDPI/46131

Idioma(s)

eng

Publicador

São Paulo

Relação

Brazilian Journal of Pharmaceutical Sciences

Direitos

openAccess

Palavras-Chave #USO DE MEDICAMENTOS #FARMACÊUTICOS
Tipo

article

abstracts

publishedVersion